2006Journal of Huaihai MedicineRequires access

Clinical study of the treatment of patients with congestive heart failure by using valsartan combined with enalapril

Yu Ka

Open publisher page 0 citations

Abstract

Objective To probe the treatment of patients with congestive heart failure(CHF) by using valsartan combined with enalapril.Methods Forty patients were randomly divided into two groups.Treatment group(n=20)was given valsartan 80 mg/d and enalapril 5~10 mg/d.Contol group(n=20)was given enalapril 5~10 mg/d.The changes of NYHA rating,biochemistry,liver and renal function,electrocardiogram and echocardiography were observed.Results After eight weeks' therapy,NYHA rating,LA atrium diameter,LV end-distolic volume(EDV),LV end-systolic volume(ESV),left ventricular ejection fraction(EF),fraction shortening(FS),cardiac output(CO),cardiac index(CI) were improved significantly in both groups(P0.05).LVEDV,LVESV,EF and FS were more remarkable in treatment group than those in control group(P0.05).There was no significant difference in adverse reaction and liver,renal function between the two groups(P0.05).Conclusion Combining valsartan with enalapril can be used in the treatment of patients with CHF and is more effective.

About this research paper

What this paper is about

Objective To probe the treatment of patients with congestive heart failure(CHF) by using valsartan combined with enalapril.Methods Forty patients were randomly divided into two groups.Treatment group(n=20)was given valsartan 80 mg/d and enalapril 5~10 mg/d.Contol group(n=20)was given enalapril 5~10 mg/d.The changes of NYHA rating,biochemistry,liver and renal function,electrocardiogram and echocardiography were observed.Results After eight weeks' therapy,NYHA rating,LA atrium diameter,LV end-distolic volume(EDV),LV end-systolic volume(ESV),left ventricular ejection fraction(EF),fraction shortening(FS),cardiac output(CO),cardiac index(CI) were improved significantly in both groups(P0.05).LVEDV,LVESV,EF and FS were more remarkable in treatment group than those in control group(P0.05).There was no significant difference in adverse reaction and liver,renal function between the two groups(P0.05).Conclusion Combining valsartan with enalapril can be used in the treatment of patients with CHF and is more effective.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To probe the treatment of patients with congestive heart failure(CHF) by using valsartan combined with enalapril.Methods Forty patients were randomly divided into two groups.Treatment group(n=20)was given valsartan 80 mg/d and enalapril 5~10 mg/d.Contol group(n=20)was given enalapril 5~10 mg/d.The changes of NYHA rating,biochemistry,liver and renal function,electrocardiogram and echocardiography were observed.Results After eight weeks' therapy,NYHA rating,LA atrium diameter,LV end-distolic volume(EDV),LV end-systolic volume(ESV),left ventricular ejection fraction(EF),fraction shortening(FS),cardiac output(CO),cardiac index(CI) were improved significantly in both groups(P0.05).LVEDV,LVESV,EF and FS were more remarkable in treatment group than those in control group(P0.05).There was no significant difference in adverse reaction and liver,renal function between the two groups(P0.05).Conclusion Combining valsartan with enalapril can be used in the treatment of patients with CHF and is more effective.

Key concepts: Enalapril, Valsartan, Medicine, Ejection fraction, Heart failure, Cardiology, Internal medicine, Cardiac function curve

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical study of the treatment of patients with congestive heart failure by using valsartan combined with enalapril — Research Paper | ScholarLens